2019 report about drugs in France
13.11.2019 - Annual report sent by the OFDT to the EMCDDA within the Reitox framework.Read more
Female-oriented programmes in addiction care
29.10.2019 - Results from the Ad-femina survey in Tendances No. 130.Read more
Drugs, Key data 2019 - France
29.10.2019 - Overall perspective digest with the most recent and detailed facts and figures.Read more
Latest news from the EMCDDA
The Reitox network: frequently asked questions
15.10.2019 - This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs observatories. It is a reference tool for both EU Member States and countries further afield on the network, its members, its role and development
Developments in the European cannabis market
25.06.2019 - Cannabis products have become increasingly diverse in Europe. This report report explores the issues that it raises.
Laura d’Arrigo reelected as EMCDDA's Chair
14.12.2018 - The EU agency's Management Board held elections for the positions of Chair and Vice-Chair of the Board.
Quick access to the EMCDDA main publications archives
Drugs in Europe
What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2019 EMCDDA European Drug Report.
Country drug reports 2019
Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.